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Original research article
HIV testing amongst older sexual
health clinic attendees in England:
an epidemiological study
Sadie Bell1 , Joy Adamson2, Fabiola Martin3 and Tim Doran4
Abstract
Older adults with HIV are at increased risk of late diagnosis. We aimed to explore the association between age and HIV
testing rates in sexual health clinics in England using Public Health England data for 2009–2014. We investigated
associations between attendee age and likelihood of HIV test offer, acceptance, and coverage. For each year, increasing
age was associated with reduced likelihood of test offer (Rs 0.797 to 0.958, p< 001). Offer rates were highest for
men who have sex with men (MSM), and lowest for heterosexual females (HSFs). HSFs had the greatest decline in offer
rates with age (from 86.2% for age 25–29 to 52.1% for age 70þ in 2014). Odds ratios for test offer in 2014 for attendees
aged 15–49 compared with attendees aged 50þ were 1.94 (95%CI: 1.88, 2.00) for heterosexual males (HSMs), 1.86 (95%
CI: 1.81, 1.91) for HSFs, and 1.54 (95%CI: 1.45, 1.64) for MSM. Overall, there was no significant association between age
and test acceptance in any year (Rs 0.070 to 0.547; p> 005). The strongest determinant of acceptance was sexual
orientation; for attenders aged 50þ, compared with HSMs, acceptance was higher for MSM (OR: 1.10; 95%CI: 1.06,
1.13) and lower for HSFs (OR: 0.30; 95%CI: 0.30, 0.31).
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Introduction
A major obstacle to tackling HIV is people being
unaware of having the infection. In 2016, the United
Nations Secretary General reported that only half an
estimated 36.7 million people living with HIV world-
wide were aware of their infection.1,2 Levels of aware-
ness are greater in the UK, but even here it is estimated
that over 13,000 people (13% of all cases) are living
with undiagnosed HIV.3 Globally, UNAIDS aims to
increase the proportion of people aware of their HIV
status to 90% by 2020.4 To encourage HIV test uptake
the World Health Organisation has endorsed the offer
of testing in a range of healthcare and community set-
tings.5–7 UK National Guidelines for HIV Testing 2008
recommend universal testing in several healthcare facil-
ities including sexual health and antenatal services.8–10
Universal testing is recommended for new general prac-
tice registrants and hospital admissions in areas of high
HIV prevalence (2 cases per 1000 population aged
15–59 years).9,10 These recommendations intend to
increase testing and reduce late HIV diagnoses (defined
as CD4 cell count <350 cells/ml within three months of
diagnosis).9 Late diagnosis is associated with signifi-
cantly poorer immediate and long-term health out-
comes, greater likelihood of HIV transmission, and
higher treatment costs.11–15
Older adults, aged 50þ years, are at increased risk of
late HIV diagnosis.16 A comparison of UK reports for
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2000 and 2015 shows the number of new HIV diagno-
ses per annum in the over 50s more than trebled, from
333 to 1018 cases,17 and 58% of those diagnosed in
2013 received a late HIV diagnosis compared to 39%
of 15- to 49-year-olds.18 In the over 50s, prompt HIV
diagnosis and treatment is particularly crucial as the
absolute risk of developing acquired immunodeficiency
syndrome (AIDS) increases with advancing age.19 A
key factor associated with increased late diagnoses in
older adults is a misjudged risk assessment. HIV has
historically been portrayed as a young person’s dis-
ease16 and this may prevent older adults from consid-
ering themselves at risk of infection.20,21 Similarly,
clinicians may be unaware of the increasing HIV prev-
alence in older populations, and HIV infection may not
be considered in the differential diagnosis of symptoms
associated with HIV/AIDS.22
Given the higher mortality and morbidity associated
with late HIV diagnosis in older adults, compounded
by their greater risk of late diagnosis, we explored the
potential reasons for lack of HIV testing coverage in
older age groups. This is the first study which has
aimed to examine the associations between age and
sexual orientation and the offer, acceptance, and cov-
erage of HIV testing in England.
Methods
Anonymised attendance and HIV testing data for years
2009–2014 for all sexual health clinics in England were
obtained from Public Health England (PHE). It is
mandatory for sexual health clinics to collect these
data. Attendance data relate to the number of people
attending sexual health clinics per annum that are con-
sidered eligible for HIV testing (e.g. not already diag-
nosed with HIV). Testing data relate to the number of
eligible attendees that were (i) offered and (ii) accepted
the offer of an HIV test.
PHE HIV testing data are routinely presented in
broad age bands.18,23 For the purpose of this study,
we requested data in five-year age brackets from age
15 years to 70 years. To protect anonymity attendees
over 70 years were categorised by PHE into one
age bracket.
For each year, we measured associations between
age and the likelihood of (i) test offer, (ii) test offer
acceptance, and (iii) coverage, i.e. the proportion of
eligible sexual health clinic attendees that are actually
tested for HIV. We then measured these associations
by self-reported sexual orientation as categorised by
PHE: heterosexual males (HSMs), heterosexual
females (HSFs) and men who have sex with men
(MSM). PHE categorises attenders into sexual orienta-
tion groups based on the greatest HIV risk group
attendees report sexual contact with; for example,
bisexual males are reported as MSM and bisexual
females as heterosexual. The number of women who
have sex with women was too low for a meaningful
analysis (0.2% of total attenders in 2014) and was
not separately assessed.
[AQ1]Associations were measured using
Spearman’s Rho correlation coefficients. Binary com-
parisons of the odds of offer and acceptance of testing
by gender and sexual risk group were assessed using
logistic regression modelling. We hypothesised that
with advancing age the likelihood of attendees being
offered and accepting an HIV test would decline, irre-
spective of sexual risk group or year. The null hypoth-
esis was that there would be no variation by age in test
offer or acceptance. Data management and analysis
were performed using Excel and SPSS Version 23.0.
Results
In order to be tested for HIV infection, service users
must attend a sexual health clinic, be offered testing,
and accept testing. We present results for each of these
stages by age and risk group, so that the cause of dif-
ferent levels of test coverage between groups can be
determined. We conclude by reporting overall rates of
test coverage (the proportion of attendees who
are tested).
Attendance
Between 2009 and 2014 the overall number of sexual
health clinic attendees that were eligible for HIV testing
increased by 33.7% (from 1,076,466 to 1,439,212). The
number of attendees aged 15–49 years increased by
32.3% during this time period (1,020,968–1,350,563)
whilst attendees aged 50þ years increased by 59.3%
(50,917–81,136). The number of attenders in each
year is given in Table A1 (online Appendix).
For each year, higher numbers of men than women
in the 50þ age group accessed sexual health clinics: for
example, in 2014, there were approximately 56.9%
more male attendees aged 50þ years than females
(n¼ 49,553 males; n¼ 31,589 females) (Table 1). The
reverse was found for younger adults: for example, in
2014, there were approximately 35.5% more female
attendees aged 15–49 years than males (n¼ 573,451
males; n¼ 776,858 females). For each year, the major-
ity of sexual health clinic attendees aged 15–49 years
were HSFs (2014: 54.0%; n¼ 729,261/1,350,563); how-
ever, in attendees aged 50þ years the largest group was
HSMs (2014: 44.5%; n¼ 36,115/81,136) (Table 1;
Table A1).
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Test offer to attenders
Attenders in the 25–29-year age group had the highest
likelihood of receiving an offer of HIV testing (88.0%
overall in 2014), with the proportion of attendees
receiving an offer declining with age (Figure 1). Only
70.3% of attenders in the over 70 age group were
offered testing in 2014, 18 percentage points lower
than for 25- to 29-year-olds. The decline in the likeli-
hood of offer was steepest for HSFs after the age of 50,
falling to a low of 52.1% in the over 70s. Offer rates for
HSMs and MSM in 2014 were very similar up to the
age of 50–54, after which rates continued to fall for
HSMs but remained stable for MSM. In the over 70
age group, offer rates for MSM were 86.9%, 11 per-
centage points higher than for HSMs and 34.8% higher
than for HSFs.
These gaps were even greater in previous years
(Figure A1, online Appendix). Between 2009 and
2014 there were increases in the likelihood of offer
for the 65–69 (69.8–77.1%) and 70þ (57.7–70.3%)
age groups (Table A1 and Figure A1a, online
Appendix). In comparison, for adults aged 15–24
years, the percentage of attendees offered testing
declined during this time period (87.7–82.1%). For
every year and in every sexual risk group, the associa-
tion between age and offer of HIV testing was statisti-
cally significant (P< 0.001 in all cases) with increasing
age associated with lower probability of test offer (Rs
0.797 to 0.988) (Table A2, online Appendix).
Following logistic regression modelling, the odds of
being offered HIV testing in 2014 were found to be
significantly higher for eligible attendees aged 15–49
years compared to eligible attendees aged 50þ years,
for both genders and all sexual orientation groups
(Table 1). The odds ratios for test offer for attendees
aged 15–49 compared with attendees aged 50þ in 2014T
a
b
le
1
.
H
IV
te
st
in
g
u
p
ta
ke
ra
te
s
b
y
se
x
u
al
o
ri
e
n
ta
ti
o
n
.
M
al
es
H
SM
M
SM
Fe
m
al
e
s
H
SF
1
5
–
4
9
ye
ar
s
5
0
þ
ye
ar
s
1
5
–
4
9
ye
ar
s
5
0
þ
ye
ar
s
1
5
–
4
9
ye
ar
s
5
0
þ
ye
ar
s
1
5
–
4
9
ye
ar
s
5
0
þ
ye
ar
s
1
5
–
4
9
ye
ar
s
5
0
þ
ye
ar
s
A
tt
en
d
an
ce
N
o
.
o
f
at
te
n
d
ee
s
el
ig
ib
le
fo
r
te
st
in
g
5
7
3
,4
5
1
4
9
,5
3
3
4
6
0
,6
0
4
3
6
,1
1
5
9
2
,5
2
8
1
1
,4
0
8
7
7
6
,8
5
8
3
1
,5
8
9
7
2
9
,2
6
1
2
9
,6
2
3
Te
st
s
o
ff
er
ed
N
o
.
o
f
el
ig
ib
le
at
te
n
d
ee
s
o
ff
er
ed
an
H
IV
te
st
5
2
1
,9
4
9
4
1
,8
6
2
4
2
2
,1
8
8
3
0
,7
0
7
8
4
,7
8
2
1
0
,0
0
2
6
4
5
,6
9
3
2
3
,9
5
7
6
2
2
,5
1
4
2
3
,0
9
4
P
er
ce
n
t
o
ff
er
ed
9
1
.0
%
8
4
.5
%
9
1
.7
%
8
5
.0
%
9
1
.6
%
8
7
.7
%
8
3
.1
%
7
5
.8
%
8
5
.4
%
7
8
.0
%
O
d
d
s
ra
ti
o
1
.8
4
–
1
.9
4
–
1
.5
4
–
1
.8
6
–
1
.8
6
–
(9
5
%
C
I)
a
(1
.7
9
–
1
.8
9
)
(1
.8
8
–
2
.0
0
)
(1
.4
5
–
1
.6
4
)
(1
.8
1
–
1
.9
1
)
(1
.8
1
–
1
.9
1
)
Te
st
s
ac
ce
p
te
d
N
o
.
o
f
el
ig
ib
le
at
te
n
d
ee
s
ac
ce
p
ti
n
g
a
te
st
o
ff
er
4
5
0
,6
8
0
3
5
,9
1
8
3
5
6
,8
3
4
2
5
,5
6
9
8
1
,2
5
3
9
,3
9
4
4
8
3
,9
9
7
1
8
,3
3
1
4
6
7
,4
4
1
1
7
,7
0
1
P
er
ce
n
t
ac
ce
p
te
d
8
6
.3
%
8
5
.8
%
8
4
.5
%
8
3
.3
%
9
5
.8
%
9
3
.9
%
7
5
.0
%
7
6
.5
%
7
5
.1
%
7
6
.6
%
O
d
d
s
ra
ti
o
1
.0
5
–
1
.1
0
–
1
.4
9
–
0
.9
2
–
0
.9
2
–
(9
5
%
C
I)
a
(1
.0
2
–
1
.0
8
)
(1
.0
6
–
1
.1
3
(1
.3
6
–
1
.6
3
)
(0
.8
9
–
0
.9
5
)
(0
.8
9
–
0
.9
5
)
Te
st
co
ve
ra
ge
N
o
.
o
f
el
ig
ib
le
at
te
n
d
ee
s
te
st
ed
4
5
0
,6
8
0
3
5
,9
1
8
3
5
6
,8
3
4
2
5
,5
6
9
8
1
,2
5
3
9
,3
9
4
4
8
3
,9
9
7
1
8
,3
3
1
4
6
7
,4
4
1
1
7
,7
0
1
P
er
ce
n
t
te
st
ed
7
8
.6
%
7
2
.5
%
7
7
.5
%
7
0
.8
%
8
7
.8
%
8
2
.3
%
6
2
.3
%
5
8
.0
%
6
4
.1
%
5
9
.8
%
O
d
d
s
ra
ti
o
1
.3
7
–
1
.4
2
–
1
.5
5
–
1
.2
0
–
1
.2
0
–
(9
5
%
C
I)
a
(1
.3
4
–
1
.4
0
)
(1
.3
9
–
1
.4
5
)
(1
.4
7
–
1
.6
3
)
(1
.1
8
–
1
.2
3
)
(1
.1
7
–
1
.2
3
)
H
SF
:
h
et
er
o
se
x
u
al
fe
m
al
e;
H
SM
:
h
et
er
o
se
x
u
al
m
al
e;
M
SM
:
m
en
w
h
o
h
av
e
se
x
w
it
h
m
en
.
a A
ge
5
0
þ
ye
ar
s
is
th
e
co
m
p
ar
at
o
r
gr
o
u
p.
30%
40%
50%
60%
70%
80%
90%
100%
%
 O
F
 A
T
T
E
N
D
E
E
S
 O
F
F
E
R
E
D
 H
IV
 T
E
S
T
IN
G
15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70+
AGE GROUP (YEARS)
Heterosexual females Heterosexual males MSM Total (all groups)
Figure 1. Proportion of sexual health clinic attendees offered
an HIV test by sexual orientation and age – 2014, England. MSM:
men who have sex with men.
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were 1.84 (95%CI: 1.79–1.89) for males and 1.86 (95%
CI: 1.81–1.91) for females. By sexual orientation, the
odds ratios for test offer for attendees aged 15–49 com-
pared with attendees aged 50þ in 2014 were 1.94 (95%
CI: 1.88–2.00) for HSMs, 1.86 (95%CI: 1.81–1.91) for
HSFs and 1.54 (95%CI: 1.45–1.64) for MSM.
Comparing sexual orientation groups, the odds of
test offer in adults aged 50þ years in 2014 were highest
for MSM and HSMs, and lowest for HSFs (Table 2).
Test acceptance after offer
Overall, of attendees offered testing in 2014, those aged
55–59 and 65–69 years were the most likely to accept,
and those aged 15–19 were least likely (Figure 2).
Whilst rates of acceptance in every age group were
highest for MSM and lowest for HSFs, the general
patterns of acceptance across all age groups were
broadly similar for all sexual orientation groups.
Similar trends were evident in previous years
(Figure A2, online Appendix).
Given the patterns described above, the association
between age and test acceptance was not as clear as for
offer of testing. The association was only statistically
significant in every year for MSM (P< 0.05 in all cases:
Table A2, online Appendix), with increasing age
associated with lower probability of test acceptance
(Rs 0.600 to 0.954). However, for MSM acceptance
rates in each year were relatively high for all age
groups. For example, in 2014, the difference between
the 20–24 and over 70 age groups for MSM was only
3.8 percentage points, and acceptance rates in every age
group from MSM were over 90%.
Findings from logistic regression modelling
(Table 1) suggest that older MSM and HSMs are less
likely to accept an HIV test than their younger com-
parators. For HSFs, attenders aged 50 years and over
are slightly more likely to accept testing than their
younger comparators. However, the strongest determi-
nant of test acceptance was sexual orientation. For
older attenders, compared with HSMs the odds of
test acceptance are highest for MSM (OR¼ 1.10) and
lowest for HSFs (OR¼ 0.30) (Table 2).
Test coverage
Overall, 85.7% of attendees were offered testing, of
whom 81.5% accepted (coverage rate of 69.9%). In
2014, attenders aged 25–29 years had the highest like-
lihood of HIV test coverage (72.7% overall), with the
proportion of attenders being tested declining with age
thereafter (Figure 3). The youngest and the oldest age
group were least likely to be tested for HIV in 2014
(58.6% in 15–19 years; 56.7% in 70þ years). Between
2009 and 2014, the proportion of tests performed in
Table 2. Odds of HIV test uptake by sexual orientation, ages 50. [AQ9]
HSM MSM HSF
Attendance No. of attendees eligible for testing 36,115 11,408 29,623
Tests offered No. of eligible attendees offered an HIV test 30,707 10,002 23,094
Per cent offered 85.00% 87.70% 78.00%
Odds ratio – 1.25 0.55
(95%CI)a (1.18–1.33) (0.53–0.58)
Tests accepted No. of eligible attendees accepting a test offer 25,569 9394 17,701
Per cent accepted 83.30% 93.90% 76.60%
Odds ratio – 1.1 0.3
(95%CI)a * (1.06–1.13) (0.30–0.31)
Test coverage No. of eligible attendees tested 25,569 9394 17,701
Per cent tested 70.80% 82.30% 59.80%
Odds ratio – 1.92 0.61
(95%CI)a (1.82–2.03) (0.59–0.63)
HSF: heterosexual female; HSM: heterosexual male; MSM: men who have sex with men.
aHeterosexual males are the comparator group.
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Figure 2. Proportion of sexual health clinic attendees accepting
an HIV test by sexual orientation and age – 2014, England. MSM:
men who have sex with men.
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each age group increased in the over 50s, particularly
in attendees aged 65–69 (54.4–64.1%) and 70þ
(44.5–56.7%), and declined in adults aged 15–49
years, particularly those aged 15–19 years
(64.6–58.6%) (Figure A3, online Appendix).
Test coverage varied considerably by sexual orienta-
tion. In 2014, HSFs were least likely to be tested at any
age and had the sharpest fall in testing rates with
increasing age: the likelihood of being tested dropped
to just 37.3% in HSFs aged 70þ years, compared to
59.8% in HSMs and 80.8% in MSM (Figure 3). Similar
trends were evident in preceding years (Figure A3,
online Appendix). In every year the association
between age and test coverage was statistically signifi-
cant for HSMs and MSM, with increasing age associ-
ated with lower probability of being tested (Rs 0.734
to 0.951).
Following logistic regression modelling, the odds of
being tested for HIV in 2014 were significantly higher
for eligible attendees aged 15–49 years compared to
those aged 50þ years by sex and sexual orientation
(Table 1). The difference in the odds of being tested
between age groups was greater for males than for
females, but males, especially MSM, had a higher
chance of being tested across all age groups
(Table A2, online Appendix).
Discussion
We discovered that advancing age is significantly asso-
ciated with a decreased likelihood of being tested for
HIV in sexual health clinics in England. This was
mainly attributable to a decline in the rate of test
offer to older people, particularly to HSFs. This
inequality in HIV test offer by age exists despite nation-
al and international recommendations of universal
HIV testing in this setting.9 A major barrier reported
to underpin lower test offers and a reluctance to discuss
sexually transmitted infections (STIs) with older adults
is the assumption that STIs affect the young, and that
older adults do not engage in ‘risky’ unprotected
sex.20,24 This impression arguably stems historically
from the STI and HIV prevention campaigns focusing
mainly on younger adults.20,25–27 This fuels the percep-
tion that older people are not at risk of HIV transmis-
sion, an impression reinforced by the societal
stereotype of the risk averse, asexual older adult.20
There is evidence that these misrepresentations may
also influence clinicians. In general practice, stalemates
on the issue of sexual health have been reported
between patient and healthcare provider.28,29 Older
adults have been identified as reluctant to discuss
their sexual health with a general practitioner,28 and
healthcare professionals report being uncomfortable
to raise the subject for fear of causing upset or embar-
rassment.29However, in sexual health clinics this would
be a less obvious explanation for the observed lower
test offer rates for older attendees. There is a clear need
to explore the factors associated with the test offer gap,
and any barriers identified are likely to be even greater
in settings with less clinical experience of manag-
ing HIV.
Impact of sexual orientation and age on HIV testing
MSM are disproportionately affected by HIV in the
UK; 5.0% of MSM aged 15–44 years are living with
HIV in contrast to approximately 0.1% of age-
comparable HSMs and HSFs.23 In response, MSM
are consistently targeted in national HIV prevention
and testing strategies.15,30–32 The success of these
approaches can be shown by the low proportion of
late HIV diagnoses and undiagnosed infections in
MSM compared to other risk groups.23 The effective-
ness of HIV strategies targeting MSM is reflected in
our study by the high test uptake for MSM attending
sexual health clinics; in every year, MSM had the high-
est rate of HIV testing and advancing age did not sub-
stantially reduce the likelihood of either being offered
or accepting an HIV test.
By falling outside of the MSM risk group, the prob-
ability of eligible HSM and HSF sexual health clinic
attendees being offered an HIV test is lowered. This
effect becomes more marked in older HSMs and
HSFs, who are not only less likely to be offered a test
due to their sexual orientation but also their age,
despite attending clinics where universal HIV testing
is recommended. HSFs are the least likely group to
be offered HIV testing and are generally considered
to be at lower HIV risk than HSMs, who are much
more likely to report paying for sex, having sexual con-
tact with someone from outside the UK, and are less
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Figure 3. HIV test coverage in sexual health clinics by age and
sexual risk group – England, 2014. MSM: men who have sex
with men.
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likely to use condoms than HSFs.33 Males are also
more likely to use intravenous drugs than females.34
This may create the impression that HIV testing is
less of a priority for females, and this perception may
be reinforced by other aspects of the attendee history
that are not captured in the PHE data. Our findings
suggest that substantial numbers of older women are
being excluded from testing, and this is likely to have
serious consequences for the health outcomes of
women with HIV infection.
Another factor which may be a barrier to offering an
HIV test to younger women (pre-menopausal age) is
that their reason for attendance may not be for a STI
screen. This group may also use a clinic for family
planning services, perhaps to access contraception,
and the reason for attendance may therefore detract
healthcare providers from offering an HIV test.35 In
older HSFs, however, there is no obvious factor that
can be attributed to the lower likelihood of being
offered HIV testing in a setting where universal HIV
testing is recommended, other than being considered to
be at lower HIV risk.
Limitations
This study is dependent on the accuracy of reporting of
attendance and HIV testing by sexual health services to
PHE, and any trend towards more complete reporting
in any particular age or risk group will have biased our
results. The available data also omit other important
variables, such as ethnicity, which are associated with
HIV testing. Misclassification is unlikely to have affect-
ed reported age or sex groups, but may have affected
sexual orientation.36
Analyses, particularly regressions, were limited by
the data format. Data received from PHE are presented
in cells (e.g. number of MSM aged 50–54 offered HIV
testing) rather than at the individual attendee level, and
several important attendee characteristics are not
reported. It was therefore not possible to adjust for
all potential confounders. In addition, Spearman’s
rank correlation coefficient was considered the most
appropriate statistical test given the ordinal nature of
the data,37 but this test overlooks the degree of varia-
tion within the data and does not provide an estimate
of the strength of association between variables.
Conclusions
Despite their mandate to offer universal HIV testing,
sexual health clinics in England are less likely to offer
testing to attendees with increasing age. Sexual orien-
tation is also strongly associated with the likelihood of
being offered an HIV test, and many heterosexual
women – particularly those in older age groups – are
currently being overlooked, likely due to a perception
of lower risk. This is compounded by the lower rate of
test acceptance by this population group; heterosexual
women were the least likely to accept an offer of testing
and acceptance rates decreased with increasing age (as
was the case with HSMs), although this effect was not
as marked as for test offer. In contrast, rates of test
acceptance by MSM remained consistently high across
all age groups, which suggest that attendees’ percep-
tions of their own risk align with the perceptions of
healthcare professionals. Effective interventions to
increase test offer and uptake of universal HIV testing
will therefore need to target both attendees and pro-
viders, and such interventions are urgently required.
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